Results 201 to 210 of about 132,766 (257)

Dietetic‐Led Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: Feasibility, Acceptability, and Proof‐of‐Concept

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder (CBT‐AR) is an emerging treatment for ARFID, but to date, it has only been delivered by mental health clinicians. Given the relevance of nutrition to treatment goals, we adapted the treatment to be dietetic‐led (D‐CBT‐AR).
Copeland G. Winten, Esben Strodl, Gabriella Heruc, Joanne Avery, Kamryn T. Eddy, Lynda J. Ross, Jennifer J. Thomas   +6 more
wiley   +1 more source

Applying artificial intelligence in neurodevelopmental disorders management and research. [PDF]

Eur J Med Res
Mohamed S, Ben-Jaafar A, Frimpong M, Roy S, Sanker V, Nkrumah-Boateng PA, Imran S, Mumeen AA, Mohamed S, Wireko AA.   +9 more
europepmc   +1 more source

Risk assessment using IEUBK model for the Naica mine tailings

Environmental Progress &Sustainable Energy, EarlyView.
Abstract Mexico has a long history of mineral extraction, during which limited environmental regulations allowed the accumulation of toxic waste near communities, primarily in rural or undeveloped areas. Some of these toxic substances, such as lead, pose significant risks to vulnerable populations, particularly children aged 0 to 7 years.
A. Contreras‐Guardiola, M. A. Olmos‐Márquez, L. Cortés‐Palacios, E. Santellano‐Estrada, M. C. Valles‐Aragón   +4 more
wiley   +1 more source

Prenatal exposure to asthma medications and risk of neurodevelopmental disorders and educational difficulties: A systematic review and meta-analysis. [PDF]

PLoS Med
Shakhshir LA, Karain A, Pell JP, Hastie CE, Nelson SM, Fleming M.   +5 more
europepmc   +1 more source

Epilepsy characteristics in patients with muscle‐eye‐brain disease: A systematic review of electroclinical features

Epileptic Disorders, EarlyView.
Abstract Background and Objectives Muscle‐Eye‐Brain disease (MEB) is a dystroglycanopathy that belongs to the congenital muscular dystrophies. Central nervous system manifestations include congenital brain abnormalities, neurodevelopmental delay, and epilepsy, making it a rare but important cause of developmental and epileptic encephalopathy.
Stefania Kalampokini, Evripidis Pityrigkas, Eleni Liouta, Georgia Pepe, Vasiliki Poulidou, Martha Spilioti, Vasilios K. Kimiskidis   +6 more
wiley   +1 more source

Artificial intelligence support for diagnosis of neurodevelopmental disorders during childhood: an umbrella review. [PDF]

Front Psychiatry
Alberca-González A, Fernández-Jiménez E.   +1 more
europepmc   +1 more source

"No Words Needed": Results of a Survey on How Parents of Children With Neurodevelopmental Disorders Perceive (In)formal Peer Support. [PDF]

Child Care Health Dev
Verkooijen M, Ketelaar M, Te Grefte L, Tendolkar I, Staal W, Zinkstok J.   +5 more
europepmc   +1 more source

Reconciling the Use of Human Fetal Tissue in Research

Annals of the Child Neurology Society, EarlyView.
Harvey B. Sarnat, William D. Graf, Mark S. Scher, Phillip L. Pearl, Laura Flores‐Sarnat   +4 more
wiley   +1 more source

The pediatrician's role in the follow-up of children/adolescents with mental and/or neurodevelopmental disorders. [PDF]

J Pediatr (Rio J)
Nunes ML.
europepmc   +1 more source

N. Paul Rosman, M.D. (1934–2026)

Annals of the Child Neurology Society, EarlyView.
Alcy Torres, Laurie Douglass, Phillip L. Pearl, Karl Kuban   +3 more
wiley   +1 more source